Evidence map›Paper›PMID 33587197›Full record

ReviewClinical rheumatology2021

Post-COVID-19 arthritis: a case report and literature review.

M Gasparotto, V Framba, C Piovella, A Doria, Luca Iaccarino

Open access · hybridAbstract readCase ReportsReview
In one paragraph

Review in Clinical rheumatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 112 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Inflammatory Arthritis After COVID-19: A Case Series.The American journal of case reports · 2023
    Article
  15. Review
  16. Article
  17. Reactive arthritis following COVID-19: cause for concern.Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA · 2023
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

M Gasparotto *Rheumatology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.
V Framba *Internal Medicine Unit and Regional Liver Disease Reference Centre, Department of Medicine - DIMED, University of Padua, Padua, Italy.
C PiovellaInternal Medicine Unit and Regional Liver Disease Reference Centre, Department of Medicine - DIMED, University of Padua, Padua, Italy.
A DoriaRheumatology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy.
Luca IaccarinoRheumatology Unit, Department of Medicine-DIMED, University of Padua, Padua, Italy. luca.iaccarino@unipd.it.
University of Padua · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) is the novel pathogen responsible for the coronavirus disease 19 (COVID-19) outbreak. Researchers and clinicians are exploring the pathogenetic mechanisms of the viral-induced damage and growing interest is focusing on the short-term and long-term immune-mediated consequences triggered by the infection. We will focus on post-SARS-CoV2 infection arthritis which may arise as a new pathological condition associated with COVID-19. In this article, we describe a case of acute oligoarthritis occurring 13 days after a SARS-CoV2 severe pneumonia in a middle-aged Caucasian man and we go over a brief review of the current available literature. We hypothesize that molecular mimicry might be the basic immunological mechanism responsible for the onset of COVID-19-related arthritis based on the current knowledge of SARS-CoV2 and on the known pathogenetic mechanism of viral-induced arthritis.

Indexed as

ArthritisCOVID-19HumansMaleMiddle AgedRNA, ViralSARS-CoV-2RNA, ViralArthritisCOVID-19Molecular mimicryReactive arthritisSARS-CoV2

Identifiers

PMID33587197
PMCPMC7882861
OpenAlexW3131168926

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.